Protection against the omicron variant from previous SARS-CoV-2 infection
![Thumbnail](/xmlui/bitstream/handle/10576/32089/nejmc2200133.pdf.jpg?sequence=4&isAllowed=y)
عرض / فتح
التاريخ
2022-03-31المؤلف
Altarawneh, Heba N.Chemaitelly, Hiam
Hasan, Mohammad R.
Ayoub, Houssein H.
Qassim, Suelen
AlMukdad, Sawsan
Coyle, Peter
Yassine, Hadi M.
Al-Khatib, Hebah A.
Benslimane, Fatiha M.
Al-Kanaani, Zaina
Al-Kuwari, Einas
Jeremijenko, Andrew
Kaleeckal, Anvar H.
Latif, Ali N.
Shaik, Riyazuddin M.
Abdul-Rahim, Hanan F.
Nasrallah, Gheyath K.
Al-Kuwari, Mohamed G.
Butt, Adeel A.
Al-Romaihi, Hamad E.
Al-Thani, Mohamed H.
Al-Khal, Abdullatif
Bertollini, Roberto
Tang, Patrick
Abu-Raddad, Laith J.
...show more authors ...show less authors
البيانات الوصفية
عرض كامل للتسجيلةالملخص
Natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits strong protection against reinfection with the B.1.1.7 (alpha),1,2 B.1.351 (beta),1 and B.1.617.2 (delta)3 variants. However, the B.1.1.529 (omicron) variant harbors multiple mutations that can mediate immune evasion. We estimated the effectiveness of previous infection in preventing symptomatic new cases caused by omicron and other SARS-CoV-2 variants in Qatar. In this study, we extracted data regarding coronavirus disease 2019 (Covid-19) laboratory testing, vaccination, clinical infection data, and related demographic details from the national SARS-CoV-2 databases, which include all results of polymerase-chain-reaction (PCR) testing, vaccinations, and hospitalizations and deaths for Covid-19 in Qatar since the start of the pandemic.
معرّف المصادر الموحد
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85125264303&origin=inwardالمجموعات
- الأبحاث [727 items ]
- أبحاث فيروس كورونا المستجد (كوفيد-19) [818 items ]